Diagnostic News and Research

RSS

An infectious disease expert may reduce risk of death for patients with sepsis

When people with severe sepsis, an extreme overreaction by the body to a serious infection, come to the emergency room, they require timely, expert care to prevent organ failure and even death.

31 Oct 2019

New strategies and approaches to treat patients with hypertension

While studies of hypertension have been performed worldwide in a variety of epidemiological settings such as diabetes, renal function, obesity and thyroid disorders, there is a need to identify appropriate treatment strategies.

30 Oct 2019

MRI contrast agent enables early detection of liver disease

Researchers have developed a new MRI contrast dye that enables more accurate and safer detection of early-stage liver disease than currently approved agents.

30 Oct 2019

Beckman Coulter receives BARDA funding to develop novel sepsis detection algorithm

Beckman Coulter, Inc., a Danaher company, today announced that it has initially been awarded a contract of $1.25 million, with potential to be awarded an additional $6.5 million if all contract options are exercised, from the DRIVe (Division of Research, Innovation, and Ventures) established by the Biomedical Advanced Research and Development Authority, under the Office of the Assistant Secretary for Preparedness and Response, within the United States Department of Health and Human Services.

From Beckman Coulter Diagnostics 30 Oct 2019

New BD MAX Check-Points CPO assay receives FDA 510(k) clearance

BD (Becton, Dickinson and Company), a leading global medical technology company, along with Check-Points Health B.V., announced today that FDA 510(k) clearance was obtained for a molecular screening test for antibiotic-resistant carbapenemase-producing organisms on the fully-automated BD MAX System.

From BD (Becton, Dickinson and Company) 30 Oct 2019

GX Sciences now offers quick and easy blood analysis testing through unique Mitra device

GX Sciences is now offering quick and easy blood analysis testing, known as Microsampling, through a unique Mitra device, by Neoteryx. Blood Microsampling is an efficient and more simplified method of traditional blood sampling that allows patients to draw their own blood and securely mail the samples to the GX Sciences lab for analysis.

From Neoteryx, LLC 30 Oct 2019

Novel, cost-effective method successfully identifies aggressive tumors

Researchers have developed a novel, cost-effective genomic method that can identify highly heterogenous tumors that are typically aggressive in nature.

30 Oct 2019

New set of recommendations designed to strengthen translational research

Translation, i.e. the process of applying basic scientific research into new preventative, diagnostic and therapeutic procedures for use on humans, is one of the main responsibilities of university medical centers.

30 Oct 2019

Rock icon receives replacement heart valve in New York City hospital

Mick Jagger owes some thanks for the fact he's alive and strutting to Ajit Yoganathan and his lab crew. In fact, millions of people do.

30 Oct 2019

Brain function changes could help diagnose and manage depression

Ever heard of the lateral habenula? Very few, outside of neuroscience, probably have. Yet a new study, published in the journal Neuron, shows that characteristic changes in the way this area of the brain fires can result in a total loss of will to do anything – which is characteristic of one form of depression.

29 Oct 2019

Study: Psychiatric diagnoses seldom used as entry criteria for NHS mental health services

A new study, published in the Journal of Mental Health, finds psychiatric diagnoses are seldom used as entry criteria for NHS mental health services in the UK.

29 Oct 2019

Discontinuing popular over-the-counter vitamin can lead of reversal of retinal swelling

In a first-of-its-kind clinical report, retina specialists at the New York Eye and Ear Infirmary of Mount Sinai have shown that severe vision loss from a self-prescribed high dose of over-the-counter niacin is linked to injury of a specific cell type in a patient's eye.

29 Oct 2019

Patterns of Alzheimer's-related damage differ by subtype and age of onset, study finds

Despite decades of scientific scrutiny, Alzheimer's disease researchers have yet to work out its cause or treatment. Understanding what underlies its three distinct subtypes is thought to be a promising new research avenue.

29 Oct 2019

Financial incentives significantly decrease patient preference for testing

Providing financial incentives to forego testing significantly decreases patient preference for testing, even when accounting for test benefit and risk. That is the finding of a study published in the October 2019 issue of Academic Emergency Medicine, a journal of the Society for Academic Emergency Medicine.

29 Oct 2019

Sense Biodetection raises £12.3m to develop instrument-free, point-of-care molecular diagnostic tests

Sense Biodetection Limited has today announced that it has raised £12.3m to develop its portfolio of instrument-free, point-of-care molecular diagnostic tests, a pioneering new class of diagnostic product.

29 Oct 2019

Skin cancer diagnosis using AI technology could be as accurate as clinical specialist

New clinical data published in Journal of American Medical Association demonstrates first-in-class AI algorithm is able to diagnose skin cancer with a high-level of accuracy comparable to a clinical specialist.

29 Oct 2019

UVA scientists awarded $2.7 million NIH grant to study genetic variation linked with heart disease

The National Institutes of Health has awarded a $2.7 million grant to scientists from the University of Virginia to study a genetic variation associated with coronary heart disease.

29 Oct 2019

Discovery of causal link between hydrogen sulfide and schizophrenia

Researchers from the RIKEN Center for Brain Science in Japan have found certain chemical markers that are associated with schizophrenia. They worked with lab mice with models of schizophrenia as well as post mortem brain specimens of persons with schizophrenia. The study titled, “Excess hydrogen sulfide and polysulfides production underlies a schizophrenia pathophysiology,” was published in the latest issue of the journal EMBO Molecular Medicine.

28 Oct 2019

New diagnostic technique enables grading of tumor consistency using MRI

Researchers from Charité - Universitätsmedizin Berlin have developed a new diagnostic technique which enables the grading of tumor consistency using magnetic resonance imaging (MRI). The researchers used an imaging technique known as tomoelastography to visualize the mechanical properties of liver tumors.

28 Oct 2019

Gait disorders can help predict future cognitive decline

The way people walk is an indicator of how much their brains, as well as their bodies, are aging. Scientists reporting in a special supplement to the Journal of Alzheimer's Disease say that gait disorders, particularly slowing gait, should be considered a marker of future cognitive decline.

28 Oct 2019

Diagnostic News and Research

An infectious disease expert may reduce risk of death for patients with sepsis

New strategies and approaches to treat patients with hypertension

MRI contrast agent enables early detection of liver disease

Beckman Coulter receives BARDA funding to develop novel sepsis detection algorithm

New BD MAX Check-Points CPO assay receives FDA 510(k) clearance

GX Sciences now offers quick and easy blood analysis testing through unique Mitra device

Novel, cost-effective method successfully identifies aggressive tumors

New set of recommendations designed to strengthen translational research

Rock icon receives replacement heart valve in New York City hospital

Brain function changes could help diagnose and manage depression

Study: Psychiatric diagnoses seldom used as entry criteria for NHS mental health services

Discontinuing popular over-the-counter vitamin can lead of reversal of retinal swelling

Patterns of Alzheimer's-related damage differ by subtype and age of onset, study finds

Financial incentives significantly decrease patient preference for testing

Sense Biodetection raises £12.3m to develop instrument-free, point-of-care molecular diagnostic tests

Skin cancer diagnosis using AI technology could be as accurate as clinical specialist

UVA scientists awarded $2.7 million NIH grant to study genetic variation linked with heart disease

Discovery of causal link between hydrogen sulfide and schizophrenia

New diagnostic technique enables grading of tumor consistency using MRI

Gait disorders can help predict future cognitive decline

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News